Detail of the clinical trial

Title of the trial A Phase 2, Double-Blind, Randomized, Placebo Controlled, Dose Ranging, Parallel Group Study to Evaluate the Effect of GS-6615 on Ventricular Arrhythmia in Subjects with Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronization Therapy-Defibrillator (CRT-D)
EudraCT number 2013-004430-15
Protocol number GS-US-356-0101
Sponsor Gilead Sciences, Inc., 333 Lakeside Drive,Foster City,CA 94404, United States of America
Indications Cardio-vascular diseases
Diagnosis Arrhythmia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2014
Date of approval by Institute (SÚKL) 25.11.2014
Date of approval by EC 5.11.2014
Date of initiation CT in ČR 16.2.2015
Date of ending CT in ČR 2.11.2016
Sites Fakultní nemocnice Královské Vinohrady,III. interní - kardiologická klinika,Šrobárova 50,Praha 10,100 34
Fakultní nemocnice Hradec Králové,I. interní kardioangiologická klinika,Sokolská 581,Hradec Králové,500 05
Fakultní nemocnice Olomouc,I. interní klinika ? kardiologická,I. P. Pavlova 6,Olomouc,775 20

‹‹ Back to list